Drug/Agent Toxicity by Tissue/Organ (DBCOND0028489)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00004264
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancertreatment1 / 2unknown_status
NCT00093353
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastomatreatment1completed
NCT00006345
Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphomasupportive_care2completed
NCT00317798
Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myelomatreatment1completed
NCT00025298
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynxtreatment2terminated
NCT00006105
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancertreatment2completed
NCT00003583
Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancersupportive_care2unknown_status
NCT00003811
Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumorstreatment2completed
NCT00003600
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapysupportive_care3completed
NCT00002759
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphomatreatment1completed
NCT00004036
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancersupportive_care1unknown_status
NCT00055718
Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving ChemotherapyNo drug interventionssupportive_care2completed
NCT00387374
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumabtreatment2completed
NCT00024427
Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancertreatment3completed
NCT00003580
Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancersupportive_care2completed
NCT00003144
Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumorssupportive_care1completed
NCT00397501
BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Braintreatment1 / 2withdrawn
NCT00003268
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemiatreatment1completed
NCT00075868
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancersupportive_care3completed
NCT00003269
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumorssupportive_care2completed
NCT00400946
Treatment of Acute Lymphoblastic Leukemia in Childrentreatment3completed
NCT00006012
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancertreatment1 / 2completed
NCT00028964
Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancersupportive_care1 / 2completed
NCT00052884
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantationtreatment1terminated
NCT00003251
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancersupportive_care1 / 2unknown_status
NCT00324298
Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testiclestreatment3completed
NCT00077311
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancertreatment2completed
NCT00003407
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CMLsupportive_care2withdrawn
NCT00004132
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancersupportive_care2completed
NCT00003252
Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapysupportive_care4completed
NCT00296036
Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancersupportive_care3completed
NCT00003313
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancersupportive_care3completed
NCT00002818
High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignanciestreatment1completed
NCT00005796
Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumorstreatment1completed
NCT00074165
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimentreatment2terminated
NCT00238173
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumorstreatment1terminated
NCT00004176
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancertreatment2completed
NCT00003089
Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancertreatment2completed
NCT00003068
High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancertreatment2completed
NCT00024310
Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumorstreatment1unknown_status
NCT00245050
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancersupportive_care3completed